Search Results 531-540 of 17371 for LDL

  1. Peripheral artery disease (PAD) - Doctors and departments - Mayo Clinic

    This common blood flow condition can cause leg pain when walking. Lifestyle changes and medicines can help, but sometimes surgery is needed.

  2. Peripheral artery disease (PAD) - Doctors and departments - Mayo Clinic

    This common blood flow condition can cause leg pain when walking. Lifestyle changes and medicines can help, but sometimes surgery is needed.

  3. A Study Of NST-6179 In Subjects With Intestinal Failure-Associated Liver Disease (IFALD). - Mayo Clinic

    This is a phase 2a, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK), and ...

  4. Focus areas - Liver Disease Immunobiology: Petra Hirsova - Mayo Clinic Research

    Immune mechanism and T cell pathogenicity in metabolic dysfunction-associated steatohepatitis (MASH). MASH has become a significant public health concern, ...

  5. Gastroenterology and Hepatology - Clinical trials

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  6. Chronic lymphocytic leukemia - Doctors and departments - Mayo Clinic

    Learn about this cancer that forms in white blood cells called lymphocytes. Treatments include chemotherapy, targeted therapy and immunotherapy.

  7. Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma - Mayo Clinic

    RATIONALE: Lenalidomide may stimulate the immune system in different ways and stop cancer cells from growing. Monoclonal antibodies, such as rituximab, can ...

  8. Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion - Mayo Clinic

    Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion · Share ...

  9. A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...

  10. Cardiovascular Medicine - Clinical trials

    Participants in this study will either have heart failure (HF) and are scheduled to undergo cardiac resynchronization therapy pacemaker (CRT-P) or cardiac ...